menu search

Molecular Partners to Present on its Radio DARPin Therapy (RDT) Platform at SNMMI 2023

Molecular Partners to Present on its Radio DARPin Therapy (RDT) Platform at SNMMI 2023
RDT platform offers unique approach for tailored delivery of radioactive payloads to solid tumors RDT platform is focused on improving both tumor-targeting efficiency and safety over historic protein-based radioligand approaches ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., June 27, 2023 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new […] The post Molecular Partners to Present on its Radio DARPin Therapy (RDT) Platform at... Read More
Posted: Jun 27 2023, 05:00
Author Name: forextv
Views: 110621

Search within

Pages Search Results: